Brooks O'Neil Analyst Performance

Senior Research Analyst at Lake Street Capital

Brooks O'Neil is a stock analyst at Lake Street Capital focused in the medical sector, covering 17 publicly traded companies. Over the past year, Brooks O'Neil has issued 10 stock ratings, including buy and hold recommendations. While full access to Brooks O'Neil's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Brooks O'Neil's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 29 Last 10 Years
Buy Recommendations: 82.76% 24 Buy Ratings
Companies Covered: 17 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	82.8%	24 ratings
Hold	13.8%	4 ratings
Sell	3.4%	1 ratings

Out of 29 total stock ratings issued by Brooks O'Neil at Lake Street Capital, the majority (82.8%) have been Buy recommendations, followed by 13.8% Hold and 3.4% Sell.

Best & Worst Calls

Best Call
0000.0%
RCEL
Mar 2020
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
BEAT
Feb 2019
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	82.4% of companies on NASDAQ	14 companies
NYSE	11.8% of companies on NYSE	2 companies
OTCMKTS	5.9% of companies on OTCMKTS	1 company

Brooks O'Neil, an analyst at Lake Street Capital, currently covers 17 companies listed on NASDAQ, NYSE and OTCMKTS, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 16 companies	94.1%
	Miscellaneous 1 company	5.9%

Brooks O'Neil of Lake Street Capital specializes in stock coverage within the Medical sector, with additional focus on companies.

Coverage Industries

Industry	Percentage
MED INSTRUMENTS 3 companies	17.6%
MED - DRUGS 2 companies	11.8%
MEDICAL SERVICES 2 companies	11.8%
MEDICAL INFO SYS 2 companies	11.8%
MED PRODUCTS 2 companies	11.8%
ELECTROMEDICAL EQUIPMENT 1 company	5.9%
MED - OUTP/HM CRE 1 company	5.9%
SURGICAL & MEDICAL INSTRUMENTS 1 company	5.9%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC 1 company	5.9%
MED - HMO 1 company	5.9%
Miscellaneous 1 company	5.9%

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
TNDM Tandem Diabetes Care	8/11/2025	Downgrade	$10.25	$12.00	Hold
RCEL Avita Medical	8/11/2025	Lower Price Target	$4.80	$8.00	Buy
LFMD LifeMD	8/6/2025	Lower Price Target	$6.51	$14.00	Buy
LFMD LifeMD	7/10/2025	Boost Price Target	$11.77	$18.00	Buy
PIII P3 Health Partners	4/21/2025	Lower Price Target	$9.16	$20.00	Buy
SRDX Surmodics	3/7/2025	Upgrade	$29.62	$43.00	Buy
LMAT LeMaitre Vascular	2/28/2025	Boost Price Target	$92.67	$110.00	Buy
BBNX Beta Bionics	2/24/2025	Initiated Coverage	$20.57	$30.00	Buy
SMLR Semler Scientific	1/24/2025	Boost Price Target	$54.84	$71.00	Buy
MODV ModivCare	1/13/2025	Lower Price Target	$6.52	$10.00	Buy

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.